You are here: Industry Insights > 2018

News List

Roche halts price hikes for 2018—but only after it already raised them twice fiercepharma
July 24, 2018
Roche joined a growing list of Big Pharma companies calling a halt to drug price increases—or cutting them—after President Donald Trump's naming and shaming. But that was after the Swiss drugmaker had already put through two rounds of price hikes this yea
List of Blockbuster Drugs Becoming Off-patent in 2018 W&D
July 10, 2018
Patent protection is crucial to an original drug; according to previous experience, the sales of a drug may plummet after its patent expires.
Big biopharma not the best investment so far in 2018 epvantage
July 09, 2018
It is a good year for investors to stay away from big biopharma.
Pharma shells out $100B on M&A in 2018 so far, with more to come fiercepharma
July 09, 2018
After an unusually slow 2017, deal-making in Big Pharma roared back to life in the first half of this year, with $100 billion spent on mergers and acquisitions so far.
Ophthalmic Drugs Conference 2018 worldpharmanews
June 05, 2018
As the global population ages, the incidence of ophthalmic disorders continues to grow, and thus the interest of pharmaceutical and biotech companies is increasingly focused towards innovation of novel approaches for the development of ophthalmic drugs
Pharmaceutical Enterprises to be Listed in China in 2018 Caicai
May 09, 2018
Let me tell you something horrible today: please see the “progress bar” of 2018 which is about to reach 1/3.
Roche reports a strong start in 2018 worldpharmanews
May 02, 2018
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that in the first three months of 2018, Group sales rose 6% to CHF 13.6 billion.
Takeda eyes Shire, will it be 2018’s biggest deal? biospectrumasia
April 25, 2018
Japan’s Takeda in negotiations to acquire Irish drugmaker Shire, a global rare disease drug giant. A successful acquisition will generate a global pharmaceutical powerhouse worth over $80bn with $30 bn in annual sales.
Major trends for pharma packaging in 2018 cphi-online
March 12, 2018
Experts forecast the personalised medicines, intelligent packaging and regulatory deadlines as the industry's biggest development.
Healthcare M&A outlook bright for 2018: Analysts biospectrumasia
March 08, 2018
After a subdued 2017, analysts and industry experts predict 2018 to be a robust year for healthcare M&A

Previous page 1 2 3 4 Next page